Primary completion· ClinicalTrials.gov
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
PF-07275315 History and Updates
15 events · 2022 – present
Synced daily from openFDA and ClinicalTrials.gov. Last sync: .
0
FDA Approvals
0
Label Revisions
15
Trial Milestones
0
Pivotal Publications
Source: openFDA, ClinicalTrials.gov via AACT, PubMed · Hipa.ai, 2026-06-18Download chart as PNG
This page tracks every FDA action, clinical trial milestone, and major publication for PF-07275315 since 2022, drawn from openFDA, ClinicalTrials.gov, and PubMed.
Upcoming & expected milestones
Primary completion· ClinicalTrials.gov
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Primary completion· ClinicalTrials.gov
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Past events
2026
Trial started· ClinicalTrials.gov
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Trial registered· ClinicalTrials.gov
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
2025
Primary completion· ClinicalTrials.gov
A Study to Learn More About the Study Medicine PF-07275315 in Healthy Chinese Adult Participants
Trial started· ClinicalTrials.gov
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Trial registered· ClinicalTrials.gov
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Trial started· ClinicalTrials.gov
A Study to Learn More About the Study Medicine PF-07275315 in Healthy Chinese Adult Participants
2024
Trial registered· ClinicalTrials.gov
A Study to Learn More About the Study Medicine PF-07275315 in Healthy Chinese Adult Participants
Primary completion· ClinicalTrials.gov
A Study to Learn How the Study Medicine Called PF-07275315 Works in Healthy People
2023
Trial started· ClinicalTrials.gov
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Trial registered· ClinicalTrials.gov
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
2022
Trial registered· ClinicalTrials.gov
A Study to Learn How the Study Medicine Called PF-07275315 Works in Healthy People
Trial started· ClinicalTrials.gov
A Study to Learn How the Study Medicine Called PF-07275315 Works in Healthy People
Sources
FDA approvals, label revisions, and recalls come from the public openFDA APIs (Drugs@FDA, Drug Label, Drug Enforcement). Drug-safety communications come from the FDA RSS feed. Trial milestones come from ClinicalTrials.gov via the AACT pg dump. Pivotal-publication events come from PubMed, filtered to high-impact journals linked to a Phase 3 trial in our inventory.